BASKING
RIDGE, N.J., July 10,
2024 /PRNewswire/ -- Formedics, a healthcare
media company with a dynamic healthcare professional (HCP)
engagement and marketing platform, today announced the launch of
OncWeekly, its first specialty-specific digital property to go live
since the parent company's inception. OncWeekly focuses on the
future of cancer care by providing seamless access to top-rated
cancer trials, oncology research, relevant news for clinicians, and
hyper-focused oncology content alignment for brands.
OncWeekly, a single source of accessible and actionable
information for HCPs, highlights emerging voices in next-generation
cancer care and leverages peer-to-peer interactions through robust
digital resources. The digital property features a clinical trial
database displayed in an intuitive snapshot format to support trial
recruitment while contextually relevant articles appear in the same
consolidated view.
"The Formedics audience has more than 15,000 identified HCPs
across the oncology workforce including oncologists, pathologists,
surgeons, and nurses," said Chief Executive Officer of Formedics
Greg Jackson. "We want to offer them and our brand partners a
cohesive experience that focuses on the future of clinical trials,
diagnosis, treatment, and the peer voices dedicated to addressing
inequities across the full spectrum of cancer care."
OncWeekly's content strategy, developed in consultation with
cancer care providers on oncology's front lines, centers on
advancing HCP collaboration and diversity in clinical trials:
- Foster HCP network engagement: OncWeekly taps into
partner site Figure 1's established HCP peer-to-peer collaboration
capabilities to encourage scientific exchange, share insights, and
collaborate on the challenging cases confronting oncology.
- Address diversity barriers: Black or African American
and Hispanic or Latino patients comprise less than 5% of oncology
clinical trials, a statistic disproportionate to cancer diagnoses
among the same patient populations. OncWeekly supports efforts to
improve representation and outcomes for diverse patient populations
by partnering with experts in oncology.
For brands, OncWeekly offers competitive differentiation in a
saturated oncology market with access to deep content verticals
covering more than 35 cancer types. Brands need OncWeekly to reach
the emerging generation of HCPs who are younger, more diverse, and
shaping future oncology treatment options. Early-career HCPs can
amplify brand messaging and activate reach exponentially due to
their already established social networks of HCP peers that trust
them. Through OncWeekly's audience and the capabilities of
Formedics' other properties, Physician's Weekly and Figure 1,
brands can now align their messaging with immersive oncology
content that increases brand exposure and favorability.
"OncWeekly provides precision marketing for precision medicine,"
said Chief Revenue Officer of Formedics Joe Marziani. "Brands that
need to reach targeted oncologists can do so through highly
engaging content verticals to showcase their oncology portfolio
with messaging across the site."
About Formedics, LLC
Formedics, LLC is the new parent
company of Physician's Weekly, Figure 1, and OncWeekly delivering
groundbreaking AI technology that harnesses data insights and peer
connections yielding revolutionary healthcare education and
engagement for pharmaceutical and life science brands. For more
information, please visit us at www.formedics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/formedics-establishes-digital-hub-oncweekly-to-connect-healthcare-professionals-and-brands-with-the-latest-in-oncology-302192735.html
SOURCE Formedics, LLC